Cargando…

From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review

We are at an exciting moment in time with the advancement of many vaccines, including a shigella vaccine for the world. It is instructive to look at the long road that some vaccines have traveled to recognize the remarkable accomplishments of those who were pioneers, appreciate the evolution of scie...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera, Crystal M., Schmitt, Jessicia S., Chowdhry, Erum I., Riddle, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145194/
https://www.ncbi.nlm.nih.gov/pubmed/35632401
http://dx.doi.org/10.3390/vaccines10050645
_version_ 1784716231703527424
author Herrera, Crystal M.
Schmitt, Jessicia S.
Chowdhry, Erum I.
Riddle, Mark S.
author_facet Herrera, Crystal M.
Schmitt, Jessicia S.
Chowdhry, Erum I.
Riddle, Mark S.
author_sort Herrera, Crystal M.
collection PubMed
description We are at an exciting moment in time with the advancement of many vaccines, including a shigella vaccine for the world. It is instructive to look at the long road that some vaccines have traveled to recognize the remarkable accomplishments of those who were pioneers, appreciate the evolution of scientific and applied technology, and inform the future history of a vaccine that would have great potential for global health. To achieve this valuable retrospective, a narrative historical literature review was undertaken utilizing PubMed and Embase databases with relevant search terms. Retrieved articles were reviewed and information was organized into historical themes, landmark discoveries, and important vaccine development parallels. The literature reviewed was synthesized into major eras of shigella vaccine development from pathogen discovery and first attempts to empirical approaches of killed whole-cell and live-attenuated approaches, and a modern era that applied recombinant DNA engineering and structural vaccinology. The history of shigella vaccine development has largely followed the evolutionary path of vaccine development over the last 120 years, but with important lessons learned that should be considered as we embark on the future chapters of bringing to the world a safe and effective vaccine for global health.
format Online
Article
Text
id pubmed-9145194
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91451942022-05-29 From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review Herrera, Crystal M. Schmitt, Jessicia S. Chowdhry, Erum I. Riddle, Mark S. Vaccines (Basel) Review We are at an exciting moment in time with the advancement of many vaccines, including a shigella vaccine for the world. It is instructive to look at the long road that some vaccines have traveled to recognize the remarkable accomplishments of those who were pioneers, appreciate the evolution of scientific and applied technology, and inform the future history of a vaccine that would have great potential for global health. To achieve this valuable retrospective, a narrative historical literature review was undertaken utilizing PubMed and Embase databases with relevant search terms. Retrieved articles were reviewed and information was organized into historical themes, landmark discoveries, and important vaccine development parallels. The literature reviewed was synthesized into major eras of shigella vaccine development from pathogen discovery and first attempts to empirical approaches of killed whole-cell and live-attenuated approaches, and a modern era that applied recombinant DNA engineering and structural vaccinology. The history of shigella vaccine development has largely followed the evolutionary path of vaccine development over the last 120 years, but with important lessons learned that should be considered as we embark on the future chapters of bringing to the world a safe and effective vaccine for global health. MDPI 2022-04-20 /pmc/articles/PMC9145194/ /pubmed/35632401 http://dx.doi.org/10.3390/vaccines10050645 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Herrera, Crystal M.
Schmitt, Jessicia S.
Chowdhry, Erum I.
Riddle, Mark S.
From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review
title From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review
title_full From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review
title_fullStr From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review
title_full_unstemmed From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review
title_short From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review
title_sort from kiyoshi shiga to present-day shigella vaccines: a historical narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145194/
https://www.ncbi.nlm.nih.gov/pubmed/35632401
http://dx.doi.org/10.3390/vaccines10050645
work_keys_str_mv AT herreracrystalm fromkiyoshishigatopresentdayshigellavaccinesahistoricalnarrativereview
AT schmittjessicias fromkiyoshishigatopresentdayshigellavaccinesahistoricalnarrativereview
AT chowdhryerumi fromkiyoshishigatopresentdayshigellavaccinesahistoricalnarrativereview
AT riddlemarks fromkiyoshishigatopresentdayshigellavaccinesahistoricalnarrativereview